Science Media Centre (SMC) Malaysia in collaboration with the Malaysian Health Coalition (MHC) hosted their first webinar on Saturday to discuss strategies for the ‘new normal’ once the movement control order (MCO) is lifted. The panelists discussed many issues from the impact of long-term MCO on mental health to life after MCO and MCO exit strategies, as well as preparations for the new normal and the importance of effective science communication during the COVID-19 crisis.
Autism community requires increasing attention and awareness, especially in these challenging times. Universiti Putra Malaysia (UPM) in collaboration with GENIUS Kurnia, has launched an Autism Awareness campaign by providing several awareness activities in the forms of weekly challenges to commemorate the World Autism Month.
As the coronavirus pandemic claims lives and overwhelms health care systems throughout the world, scientists are closely watching several late-stage trials of the antiviral drug remdesivir. Developed to treat Ebola, remdesivir is now being tested against COVID-19.
Samples from this tiger were taken and tested after several lions and tigers at the zoo showed symptoms of respiratory illness. Public health officials believe these large cats became sick after being exposed to a zoo employee who was actively shedding virus.
Wearing face masks significantly reduced the amounts of airborne virus particles expelled from infected patients. Findings suggest surgical-style face masks could slow the transmission of coronavirus and influenza viruses.
Researchers may have found a specific area of the coronavirus that can be targeted with therapies and drugs. This finding is also likely to help in the development of COVID-19 vaccine.
Scientists found Ivermectin was able to stop the SARS-CoV-2 virus growing in cell culture within 48 hours. Experts say more testing is needed to know if it works well in people and safe to use.
A group of Malaysian scientists will collaborate to develop vaccines for COVID-19. They will embark on the testing of existing local vaccines for Infectious Bronchitis virus (IBV), an avian coronavirus, against SARS COV 2.